107 related articles for article (PubMed ID: 16326121)
1. Minimal tolerance to the bronchoprotective effect of inhaled salmeterol/fluticasone combination on allergene challenge.
Paggiaro PL; Giannini D; Di Franco A; Bacci E; Dente FL; Vagaggini B; Tonelli M; Zingoni M
Pulm Pharmacol Ther; 2006; 19(6):425-9. PubMed ID: 16326121
[TBL] [Abstract][Full Text] [Related]
2. Inhaled beclomethasone dipropionate reverts tolerance to the protective effect of salmeterol on allergen challenge.
Giannini D; Bacci E; Dente FL; Di Franco A; Vagaggini B; Testi R; Paggiaro P
Chest; 1999 Mar; 115(3):629-34. PubMed ID: 10084467
[TBL] [Abstract][Full Text] [Related]
3. Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils.
Koopmans JG; Lutter R; Jansen HM; van der Zee JS
J Allergy Clin Immunol; 2005 Nov; 116(5):1007-13. PubMed ID: 16275368
[TBL] [Abstract][Full Text] [Related]
4. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
[TBL] [Abstract][Full Text] [Related]
5. Tolerance to the protective effect of salmeterol on allergen challenge can be partially restored by the withdrawal of salmeterol regular treatment.
Giannini D; Di Franco A; Bacci E; Dente FL; Bartoli ML; Vagaggini B; Paggiaro P
Chest; 2001 Jun; 119(6):1671-5. PubMed ID: 11399689
[TBL] [Abstract][Full Text] [Related]
6. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
[TBL] [Abstract][Full Text] [Related]
7. Tolerance to the protective effect of salmeterol on allergen challenge.
Giannini D; Carletti A; Dente FL; Bacci E; Di Franco A; Vagaggini B; Paggiaro PL
Chest; 1996 Dec; 110(6):1452-7. PubMed ID: 8989060
[TBL] [Abstract][Full Text] [Related]
8. Tolerance to the protective effect of salmeterol in mild untreated asthmatics.
Giannini D; Di Franco A; Bacci E; Dente FL; Vagaggini B; Taccola M; Tonelli M; Zingoni M; Paggiaro P
Pulm Pharmacol Ther; 2003; 16(6):355-60. PubMed ID: 14580927
[TBL] [Abstract][Full Text] [Related]
9. Acute effects of salmeterol and fluticasone propionate alone and in combination on airway blood flow in patients with asthma.
Mendes ES; Rebolledo P; Wanner A
Chest; 2012 May; 141(5):1184-1189. PubMed ID: 21980058
[TBL] [Abstract][Full Text] [Related]
10. Effects of intranasal fluticasone and salmeterol on allergen-induced nasal responses.
Parameswaran K; Fanat A; O'Byrne PM
Allergy; 2006 Jun; 61(6):731-6. PubMed ID: 16677243
[TBL] [Abstract][Full Text] [Related]
11. Effect of fluticasone/salmeterol administered via a single device on exercise-induced bronchospasm in patients with persistent asthma.
Weiler JM; Nathan RA; Rupp NT; Kalberg CJ; Emmett A; Dorinsky PM
Ann Allergy Asthma Immunol; 2005 Jan; 94(1):65-72. PubMed ID: 15702819
[TBL] [Abstract][Full Text] [Related]
12. The therapeutic effects of inhaled long-acting beta2-adrenergics (LABA) and corticosteroids (ICS) are not affected by their inhalation sequence in moderate/persistent asthma.
Dal Negro RW; Micheletto C; Tognella S; Trevisan F; Guerriero M
Eur Ann Allergy Clin Immunol; 2006 May; 38(5):153-7. PubMed ID: 17058847
[TBL] [Abstract][Full Text] [Related]
13. Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma.
Koopmans JG; Lutter R; Jansen HM; van der Zee JS
Thorax; 2006 Apr; 61(4):306-12. PubMed ID: 16449264
[TBL] [Abstract][Full Text] [Related]
14. Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma.
Shapiro G; Lumry W; Wolfe J; Given J; White MV; Woodring A; Baitinger L; House K; Prillaman B; Shah T
Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):527-34. PubMed ID: 10673196
[TBL] [Abstract][Full Text] [Related]
15. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
Yates DH; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
[TBL] [Abstract][Full Text] [Related]
16. Impact of inhaled salmeterol/fluticasone propionate combination product versus budesonide on the health-related quality of life of patients with asthma.
Juniper EF; Jenkins C; Price MJ; James MH
Am J Respir Med; 2002; 1(6):435-40. PubMed ID: 14720030
[TBL] [Abstract][Full Text] [Related]
17. Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD.
Schermer TR; Albers JM; Verblackt HW; Costongs RJ; Westers P
Fam Pract; 2007 Apr; 24(2):181-8. PubMed ID: 17251178
[TBL] [Abstract][Full Text] [Related]
18. Salmeterol and fluticasone propionate given as a combination. Lack of systemic pharmacodynamic and pharmacokinetic interactions.
Kirby S; Falcoz C; Daniel MJ; Milleri S; Squassante L; Ziviani L; Ventresca GP
Eur J Clin Pharmacol; 2001; 56(11):781-91. PubMed ID: 11294367
[TBL] [Abstract][Full Text] [Related]
19. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction.
van der Woude HJ; Boorsma M; Bergqvist PB; Winter TH; Aalbers R
Pulm Pharmacol Ther; 2004; 17(2):89-95. PubMed ID: 15123230
[TBL] [Abstract][Full Text] [Related]
20. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma.
Akamatsu T; Shirai T; Kato M; Yasui H; Hashimoto D; Fujisawa T; Tsuchiya T; Inui N; Suda T; Chida K
Pulm Pharmacol Ther; 2014 Feb; 27(1):52-6. PubMed ID: 23583566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
